LIFEVANTAGE CORP Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
LIFEVANTAGE CORP (LFVN) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-08-27
- LIFEVANTAGE CORP unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- LIFEVANTAGE CORP unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $53.00K.
- LIFEVANTAGE CORP unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $0.00.
- LIFEVANTAGE CORP unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2026-06-30 | $0.00 10-K · filed 2026-08-27 |
| 2025-06-30 | $53.00K 10-K · filed 2026-08-27 |
| 2024-06-30 | $0.00 10-K · filed 2025-09-04 |
| 2022-06-30 | $0.00 10-K · filed 2022-08-23 |
| 2021-06-30 | $480.00K 10-K · filed 2022-08-23 |
| 2020-06-30 | $0.00 10-K · filed 2021-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |